Certadose

Denver, United States Founded: 2013 • Age: 13 yrs
Colour coded syringes for paediatric medication delivery
Request Access

About Certadose

Certadose is a company based in Denver (United States) founded in 2013.. Certadose has raised $16.23 million across 6 funding rounds. Certadose offers products and services including Certa Dose App, PALS Syringe Holder Kit, Epinephrine Convenience Kit, and Measuring Tape. Certadose operates in a competitive market with competitors including Sensidose, TruMed Systems, INRange Systems, Avancen and ethilog, among others.

  • Headquarter Denver, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Legal Name Certa Dose, Inc.
Operational Areas
Healthcare → Medical Devices & Diagnostics
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $16.23 M (USD)

    in 6 rounds

  • Latest Funding Round
    $8.1 M (USD), Series B

    Dec 02, 2019

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Certadose

Certadose offers a comprehensive portfolio of products and services, including Certa Dose App, PALS Syringe Holder Kit, Epinephrine Convenience Kit, and Measuring Tape. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

App for visualizing and verifying medical doses in emergencies.

Kit for accurate dosing during pediatric emergencies.

Tools for precise epinephrine dosing in anaphylaxis cases.

Device for estimating pediatric weight in medical situations.

Funding Insights of Certadose

Certadose has successfully raised a total of $16.23M across 6 strategic funding rounds. The most recent funding activity was a Series B round of $8.1 million completed in December 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 6
  • Last Round Series B — $8.1M
  • First Round

    (22 Dec 2014)

  • Investors Count
Date Amount Transaction Name Valuation Lead Investors Investors
Dec, 2019 Amount Series B - Certadose Valuation

investors

Mar, 2019 Amount Series A - Certadose Valuation

investors

Jul, 2018 Amount Series A - Certadose Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investments & Acquisitions by Certadose

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Certadose

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Certadose Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Certadose

Certadose operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sensidose, TruMed Systems, INRange Systems, Avancen and ethilog, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Individually tailored drug doses are delivered via micro-tablets system.
domain founded_year HQ Location
Vaccine management systems are provided for physician offices and hospitals.
domain founded_year HQ Location
Hardware and software for remote medication management are supplied.
domain founded_year HQ Location
Medication management devices are supplied to hospitals and patients.
domain founded_year HQ Location
Medication dispensing devices are manufactured and supplied by Ethilog.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Certadose

Frequently Asked Questions about Certadose

When was Certadose founded?

Certadose was founded in 2013 and raised its 1st funding round 1 year after it was founded.

Where is Certadose located?

Certadose is headquartered in Denver, United States. It is registered at Denver, Colorado, United States.

Who is the current CEO of Certadose?

Caleb Hernandez is the current CEO of Certadose.

Is Certadose a funded company?

Certadose is a funded company, having raised a total of $16.23M across 6 funding rounds to date. The company's 1st funding round was a Series A of $2.6M, raised on Dec 22, 2014.

What does Certadose do?

Certadose is developing a portfolio of products for paediatric care. They have developed colour coded syringes that work in conjunction with the nine colour zones of the Broselow and Hand Tevy methods to eliminate the complex math calculations and provide confidence and color confirmation in pediatric medicine dosing. The syringe has received FDA clearance.

Who are the top competitors of Certadose?

Certadose's top competitors include INRange Systems, TruMed Systems and Sensidose.

What products or services does Certadose offer?

Certadose offers Certa Dose App, PALS Syringe Holder Kit, Epinephrine Convenience Kit, and Measuring Tape.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available